Condition: Smoking · Smoking Behaviors · Tobacco Use · Sponsor: RAI Services Company
This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers
This description comes directly from the study's public registry record.
John Darnell · 3367410386 · darnelj2@rjrt.com
Kristen Prevette · 3367411873 · prevetk1@rjrt.com
Always discuss trial participation with your own doctor first.
| Dr. Vince Clinical Research | Overland Park, Kansas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07132814